Fangmeng Fu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Highly Efficient

Positive Breast Cancer

Sentinel Lymph Node

Top Venues

Breast cancer research and treatment

NPJ breast cancer

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Peng He, Jing Li, Minyan Chen, Meng Huang, Yibin Qiu, Qindong Cai, Yuxiang Lin, Chuan Wang, Fangmeng Fu
Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis. Breast cancer research and treatment (2023)
Lili Chen, Fan Wu, Xiaobin Chen, Yazhen Chen, Lin Deng, Qindong Cai, Long Wu, Wenhui Guo, Minyan Chen, Yan Li, Wenzhe Zhang, Xuan Jin, Hanxi Chen, Qian Nie, Xiong Wu, Yuxiang Lin, Chuan Wang, Fangmeng Fu
Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis. NPJ breast cancer 9 (1) (2023)
Minyan Chen, Shengmei Li, Meng Huang, Jingjing Guo, Xuan Huang, Wenhui Guo, Lili Chen, Yuxiang Lin, Lisa Jacobs, Chuan Wang, Fangmeng Fu
Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy. Breast cancer research and treatment 196 (2) (2022)
Yuxiang Lin, Jie Zhang, Yan Li, Wenhui Guo, Lili Chen, Minyan Chen, Xiaobin Chen, Wenzhe Zhang, Xuan Jin, Meichen Jiang, Han Xiao, Chuan Wang, Chuangui Song, Fangmeng Fu
CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1. Journal of translational medicine 20 (1) (2022)